Initiating Pre-exposure Prophylaxis The PrEP Checklist

Slides:



Advertisements
Similar presentations
No one left behind: Increased coverage, better programmes and maximum impact for key populations WHO Consolidated Guidelines on HIV Prevention, Diagnosis,
Advertisements

Dr. Carol Odula (Obs./Gyn.) May 7 th 2013 Preparing for pre-exposure prophylaxis (PrEP) to prevent HIV infection.
UN Cares PEP Starter Kit Custodians Training MODULE 4: HIV Post-Exposure Prophylaxis Starter Kits.
Preparing for pre-exposure prophylaxis (PrEP) to prevent HIV infection James Wilton Project Coordinator Biomedical Science of HIV Prevention
Potential role of PEP, PrEP and ART for HIV Prevention among Men who have Sex with Men Frits van Griensven, PhD, MPH Division of HIV/AIDS Prevention US.
New York State Department of Health AIDS Institute June, 2014
Are people living with HIV less likely to pass HIV to others if they are on treatment? Exploring the use of treatment as prevention James Wilton Project.
MSM 2003HIV positive 17 % 2005HIV positive 28 % 2007HIV positive 32 %
$1 Million $500,000 $100,000 $50,000 $25,000 $10,000 $5,000 $1,000.
N ORTHWEST A IDS E DUCATION AND T RAINING C ENTER Pre-exposure Prophylaxis for HIV Prevention Efficacy and the importance of adherence Joanne Stekler,
BRADFORD BRIGGS & NIKE JACKSON. BRADFORD BRIGGS Prevention Toolbox.
Hepatitis C Consultation Services (844) | 9AM-5PM ET, M-F nccc.ucsf.edu The Clinician Consultation Center (CCC) provides up-to-date expert clinical.
Conflict of Interest “No conflicts of interest to declare”.
Prepping Men who have Sex with Men for better Health Outcomes: A Conversation between Healthcare Providers and their Clients Tuesday 25th July at 11:00.
IAS Satellite Session 25th July 2017 Daniel Were, PhD
PrEP for HIV Prevention
Use of social media to improve engagement and retention in care and health outcomes for young MSM and transgender women with HIV.
A protocol in development IMPAACT Prevention Scientific Committee
Jessica Haberer, MD, MS July 24, 2017
COMBINATION PREVENTION
PrEP as an HIV Prevention Tool in Queer Communities of Color: Barriers and Opportunities BACKGROUND Joanne Stekler, MD MPH.
Provider Initiated HIV Counseling and Testing
Medication Adherence Improve the health of your patients and reduce overall health care costs.
Hepatitis C Consultation Services (844) | 9AM-8PM EST, M-F nccc.ucsf.edu The Clinician Consultation Center (CCC) provides up-to-date expert advice.
PrEP: A Case-by-Case Approach
HIV and the ART of Prevention
Provider Training Package:
Healthcare Strategies for HIV-Positive Girls and Women: Can We Do Better?
Managing Women Living With HIV Infection
Behavioral and Social Science in Biomedical HIV Research
Program Goals Overview of HIV Epidemic HIV and Communities of Color.
PrEP Effectiveness. Preexposure Prophylaxis Translating the Clinical Trials Into Clinical Practice.
Stopping the Epidemic HIV Prevention Today
Extended Half-life Factor Products in the Management of Hemophilia
Is Your Patient Engaged in Care
Statin Selection in Special Patient Populations: A Case Challenge
PrEP in Women: Unique Considerations and Strategies
Panelists. One Size May Not Fit All: A New Aspirin Option for the High-Risk Patient.
Module 6: WRAPPING UP Version: August 2018.
Blood pressure control: dependence on adherence
Assessing the State of Statin Therapy
Medication Adherence Improve the health of your patients and reduce overall health care costs.
What Does the Primary Care Physician Need to Know About Chronic Hepatitis C?
Case Study. Managing Medication and Adherence in SIHD: Partnering With the Patient to Improve Care.
Statins, HIV, and CVD.
PrEP Pre-Exposure Prophylaxis
PrEP.
Personalizing Statin Therapy in Patients With HIV
A Case-based Approach to RSV Disease
HPTN 082 Uptake and adherence to daily oral PrEP as a primary prevention strategy for young African women: A Vanguard Study.
From Start to Finish: Initial and Ongoing Care for Men Receiving PrEP
Module 6: WRAPPING UP Version: December 2018.
PrEP Ongoing Care.
Extended Half-life Factor Products in the Management of Hemophilia
Dianne Rausch, Ph.D. Director, Division of AIDS Research
The Adherence Challenge in Schizophrenia Roles of Current and Emerging Therapies.
Optimizing Joint Health in Hemophilia
Module 6: WRAPPING UP Version: August 2018.
Improving Adherence to Antiplatelet Therapy After an ACS Event
Provider Training Package:
Strategies for Infection Control in Cystic Fibrosis
HIV.
Conclusions/Implications
Swipe Right & Unite for HIV Prevention: Dating Application Use Among Rural MSM Lauren Bineau, MPHc | Dr. Carolyn Lauckner | Health Promotion & Behavior.
WHO Implementation Tool for Pre-Exposure Prophylaxis (PrEP) of HIV Infection Online Learning Resource Package 10th Annual International AIDS Society WHO.
Lesson 3: Treatment as Prevention
Provider Training Package:
Attitudes, Confidence and Knowledge towards Antiretroviral Pre-Exposure Prophylaxis (PrEP) Prescription among Healthcare Providers in Thailand Poster:
Module 6: WRAPPING UP Version: June2019.
Bob Holtkamp, Director of Prevention & Outreach
Presentation transcript:

Initiating Pre-exposure Prophylaxis The PrEP Checklist

Frequently Asked Questions About PrEP from Patients

Reduce Stigma, Prevent New HIV Infection

It’s Not Who They Are, It’s What They Do Patients Who May Be Candidates for PrEP

Risk Behavior Assessment for MSM

3 Types of HIV Tests

Gauge Adherence with the Right Questions

Free, Most-downloaded Pill Reminder Apps

PrEP Is Just 1 of Many Biomedical Interventions to Prevent HIV

PrEP Patient Checklist

Abbreviations

References

References (cont)

References (cont)

References (cont)